MAINA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 23.421
EU - Europa 20.057
AS - Asia 8.667
SA - Sud America 885
OC - Oceania 348
AF - Africa 161
Continente sconosciuto - Info sul continente non disponibili 61
Totale 53.600
Nazione #
US - Stati Uniti d'America 22.665
IT - Italia 8.031
CN - Cina 3.768
IE - Irlanda 1.951
SG - Singapore 1.777
FR - Francia 1.664
DE - Germania 1.432
SE - Svezia 1.192
UA - Ucraina 1.096
FI - Finlandia 988
KR - Corea 971
GB - Regno Unito 954
PL - Polonia 624
CA - Canada 543
BR - Brasile 475
ES - Italia 419
VN - Vietnam 408
JP - Giappone 348
NL - Olanda 345
IN - India 329
AU - Australia 294
TR - Turchia 257
RU - Federazione Russa 244
MX - Messico 170
ID - Indonesia 167
TW - Taiwan 165
BE - Belgio 163
CH - Svizzera 160
HK - Hong Kong 135
CL - Cile 121
PT - Portogallo 117
AT - Austria 114
DK - Danimarca 107
GR - Grecia 106
RO - Romania 106
CO - Colombia 94
AR - Argentina 78
IR - Iran 61
EU - Europa 58
NZ - Nuova Zelanda 54
PE - Perù 54
EC - Ecuador 50
IL - Israele 49
TH - Thailandia 49
NO - Norvegia 46
EG - Egitto 39
ZA - Sudafrica 34
PK - Pakistan 25
RS - Serbia 25
SA - Arabia Saudita 25
HU - Ungheria 23
LT - Lituania 23
TN - Tunisia 22
HR - Croazia 20
NG - Nigeria 20
CZ - Repubblica Ceca 19
PH - Filippine 19
MY - Malesia 18
SI - Slovenia 18
IS - Islanda 15
LK - Sri Lanka 15
SK - Slovacchia (Repubblica Slovacca) 14
CR - Costa Rica 13
LB - Libano 12
BG - Bulgaria 9
MA - Marocco 9
AL - Albania 8
BD - Bangladesh 8
IQ - Iraq 8
BA - Bosnia-Erzegovina 7
KE - Kenya 7
GT - Guatemala 6
NP - Nepal 6
PA - Panama 6
AE - Emirati Arabi Uniti 5
CY - Cipro 5
JO - Giordania 5
MO - Macao, regione amministrativa speciale della Cina 5
MU - Mauritius 5
VE - Venezuela 5
EE - Estonia 4
KG - Kirghizistan 4
MT - Malta 4
NI - Nicaragua 4
PR - Porto Rico 4
SN - Senegal 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
LV - Lettonia 3
QA - Qatar 3
UZ - Uzbekistan 3
A1 - Anonimo 2
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CU - Cuba 2
GE - Georgia 2
Totale 53.562
Città #
Beijing 2.463
Houston 2.237
Chandler 2.187
Dublin 1.931
Santa Clara 1.859
Singapore 1.315
Ashburn 934
Villeurbanne 898
Jacksonville 885
Fairfield 860
Milan 693
Medford 649
Ann Arbor 603
Princeton 603
Columbus 557
Wilmington 545
Redwood City 542
Woodbridge 528
Torino 522
Warsaw 501
Rome 425
Seattle 408
Nyköping 385
Turin 347
Cambridge 314
Dearborn 306
Pisa 257
Boston 244
Dong Ket 199
Guangzhou 159
Boardman 140
Toronto 137
Jakarta 120
Verona 120
Shanghai 109
Nanjing 108
Florence 96
Norwalk 96
Taipei 95
Tokyo 94
Ottawa 92
Naples 89
Bologna 83
Des Moines 82
São Paulo 81
Helsinki 78
London 78
Brussels 77
New York 74
Santiago 73
Los Angeles 72
Padova 69
Hefei 68
Vienna 68
Palermo 64
Fremont 63
Piemonte 61
Bari 60
Istanbul 60
San Diego 58
Hangzhou 57
Perugia 55
Stockholm 54
Amsterdam 53
Falls Church 53
Madrid 52
Sydney 52
Chengdu 45
Paris 45
Catania 44
Hong Kong 44
Genoa 43
Barcelona 41
Kunming 41
Lachine 41
Philadelphia 41
Central District 38
Seoul 38
Wuhan 38
Jinan 37
Pune 37
Chicago 35
Lima 35
Zhengzhou 35
Gainesville 33
Medellín 32
Melbourne 32
Mexico City 32
Nuremberg 32
Sudbury 32
Hamburg 31
Nanchang 31
Bangkok 30
Brescia 30
Changsha 30
Athens 29
Berlin 29
Trieste 29
Buenos Aires 28
Shenyang 28
Totale 28.463
Nome #
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 2.925
Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura 1.562
Disturbi bipolari e d’ansia: aspetti epidemiologici e clinici. 1.375
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 910
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. 806
Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder 599
Paliperidone palmitate and metabolic syndrome in patients with schizophrenia a 12-month observational prospective cohort study 592
Duloxetina e bupropione in pazienti con disturbo depressivo maggiore resistente agli SSRI 591
Lithium-associated hyperparathyroidism and hypercalcaemia: A case-control cross-sectional study 470
Involuntary admissions in Italy: the impact of seasonality 466
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. 445
Gender-related distribution of personality disorders in a sample of patients with panic disorder. 419
Increased uric acid levels in bipolar disorder subjects during different phases of illness. 403
Affective recurrences in bipolar disorder after switching from lithium to valproate or vice versa: A series of 57 cases 398
A randomized, single-blind comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression 387
Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions 385
Il temperamento ciclotimico nei pazienti con DOC. 380
Glucose metabolism alterations in patients with bipolar disorder. 379
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 375
Combining drug and psychological treatments for obsessive-compulsive disorder: What is the evidence, when and for whom 370
High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder 321
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 315
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 312
Sindrome metabolica e disturbi psichiatrici: confronto tra disturbo bipolare e disturbo ossessivo-compulsivo 311
Metabolic syndrome and Obsessive-Compulsive Disorder: a naturalistic Italian study 307
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. 300
Anti-brain antibodies in adult patients with obsessive-compulsive disorder 281
Brief dynamic therapy and depression severity: a single-blind, randomized study. 278
Mania mista e antidepressivi: uno studio clinico su un campione di pazienti ricoverati per disturbo bipolare 272
Anticorpi anti-SNC in adulti con disturbo ossessivo-compulsivo 271
Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. 271
General Medical Conditions Are Associated With Delay to Treatment in Patients with Bipolar Disorder. 270
Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates 264
Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase 261
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study 244
The role of the potassium channel gene KCNK2 in major depressive disorder 241
Diagnostic delay in ADHD: Duration of untreated illness and its socio-demographic and clinical predictors in a sample of adult outpatients 239
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression 236
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: Long-term results 234
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 232
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study 230
Cyclothymic temperament and major depressive disorder: A study on Italian patients 226
Obsessive-compulsive disorder and cyclothymic temperament: an exploration of clinical features 225
Terapia farmacologica della distimia: uno studio di confronto fra amisulpride, fluoxetina e lorazepam 200
The use of antidepressants in bipolar disorder 197
Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. 195
Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. 195
Il disturbo ossessivo-compulsivo di personalità (DOCP): prevalenza nei pazienti con disturbi d'ansia e nei soggetti sani 193
Efficacia e tollerabilità della Lofepramina nel trattamento della depressione nel paziente ambulatoriale 189
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 177
Differenze di genere nel disturbo ossessivo-compulsivo: uno studio clinico su 415 pazienti. 170
Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. 168
Bipolar disorders: is there an influence of seasonality or photoperiod? 164
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. 163
La stimolazione del nervo vago (VNS) nel trattamento della depressione maggiore resistente: risultati preliminari di uno studio clinico sperimentale spontaneo 163
Paziente ricoverato per episodio maniacale : trattamento con asenapina in acuto e nel lungo termine 161
Disturbo ossessivo-compulsivo sottosoglia 159
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 159
L’inquadramento nosografico dei disturbi dell’umore: dai sintomi alla diagnosi, dalla diagnosi alla terapia. 156
Impact of comorbid obsessive-compulsive disorder on suicidality in patients with bipolar disorder 152
Disturbo ossessivo-compulsivo con concomitanti disturbi da uso di sostanze: uno studio clinico 150
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy. 150
Combined treatments in obsessive-compulsive disorder: current knowledge and future prospects. 149
Can quetiapine extended release (ER) induce labial edema in a female patient with treatment-resistant major depressive episode? 148
Correlates of violent suicide attempts in patients with bipolar disorder 148
L’intervento psicoeducazionale multifamiliare (IPM) nel disturbo ossessivo-compulsivo: uno studio pilota 144
Il disturbo ossessivo-compulsivo. Epidemiologia e clinica. 143
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 142
Early childhood infections, antistreptococcal and basal ganglia antibodies in adult ADHD: a preliminary study 141
Tecniche di stimolazione cerebrale nel trattamento della depressione resistente [Brain stimulation therapies for treatment-resistant depression]. 138
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. 137
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder 137
Gender related differences in the onset of panic disorder 134
The Impact of General Medical Conditions in Obsessive-Compulsive Disorder 134
L’intervento psicoeducazionale multifamiliare nel disturbo ossessivo-compulsivo 130
Hoarding e disturbo ossessivo-compulsivo (DOC): due entità cliniche distinte in comorbilità o hoarding secondario al DOC? 130
Effectiveness of cognitive-behavioural therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study. 129
Psychiatric and physical rehabilitation intensive approach for suicide attempters by jumping from heights 129
Episodic and chronic obsessive-compulsive disorder. 128
Common and specific blood microRNA alterations in unipolar and bipolar depression 126
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 126
Trattamento farmacologico con sali di litio in pazienti affetti da disturbo bipolare: cosa succede al metabolismo del calcio? 118
Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences 117
L’influenza della comorbidità con disturbo bipolare sulla clinica del disturbo ossessivo-compulsivo 115
Studio clinico sperimentale spontaneo sul trattamento della depressione maggiore resistente mediante stimolezione del nervo vago: risultati a due anni di follow-up 115
Ansia e disturbo bipolare: comorbilità o epifenomeno? 115
A 10-year evaluation on adolescents with anxiety disorders: are they at risk of bipolarity? 115
Fenomenologia del paziente con disturbo ossessivo-compulsivo ad esordio precoce e ad esordio in età adulta 114
Definizione e strategie terapeutiche della depressione resistente al trattamento: una revisione della letteratura 112
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context 112
The concept of mixed state in bipolar disorder: from Kraepelin to DSM-5 112
[Generalized anxiety disorder. Clinical and nosological remarks] 110
ADHD nell’adulto e spettro Ossessivo-Compulsivo 108
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia. 108
Il trattamento del disturbo ossessivo-compulsivo resistente 108
Brief dynamic therapy combined with pharmacotherapy in the treatment of panic disorder with concurrent depressive symptoms. 107
Serum BDNF in OCD and major depressive disorder patients before and during antidepressant treatment. European neuropsychopharmacology 2010, 20 (3): S541-S541. 106
Validità ed affidabilità del Quality of Life, Enjoyment and Satisfaction Questionnaire, versione breve 106
La comorbidità del disturbo ossessivo-compulsivo con i disturbi di asse I: differenza tra i sessi e correlazione con il decorso clinico 106
Treatment-resistent obsessive-compulsive disorder (OCD): current knowledge and open questions 106
Totale 28.342
Categoria #
all - tutte 148.513
article - articoli 0
book - libri 0
conference - conferenze 39.225
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.527 0 0 0 0 0 0 0 512 758 420 460 377
2020/20216.052 583 299 560 345 502 432 746 299 673 489 456 668
2021/20225.262 307 252 326 303 326 255 364 378 348 276 712 1.415
2022/20238.374 891 545 335 730 702 2.143 710 556 749 243 487 283
2023/20245.077 492 665 277 349 343 488 273 397 84 417 509 783
2024/20257.384 355 863 623 1.045 2.694 1.056 480 268 0 0 0 0
Totale 55.370